Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results

Journal article

P. D. Delmas, C. L. Benhamou, Z. Man, W. Tlustochowicz, E. Matzkin, R. Eusebio, J. Zanchetta, W. P. Olszynski, Robert R. Recker and M. R. McClung

Osteoporosis International, Vol.19(7), pp.1039-1045

07/2008

PMID: 18087660

Metrics

3 Record Views

Title: Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results
Creators: P. D. Delmas (Author)
C. L. Benhamou (Author)
Z. Man (Author)
W. Tlustochowicz (Author)
E. Matzkin (Author)
R. Eusebio (Author)
J. Zanchetta (Author)
W. P. Olszynski (Author)
Robert R. Recker (Author) - Creighton University
M. R. McClung (Author)
Additional links: http://dx.doi.org/10.1007/s00198-007-0531-9
Publication Details: Osteoporosis International, Vol.19(7), pp.1039-1045
Number of pages: 1039-1045
Identifiers: 991005930907902656
Academic Unit: School of Medicine; Endocrine
Resource Type: Journal article